Literature DB >> 25729483

Post-transplantation hepatocellular carcinoma recurrence: Patterns and relation between vascularity and differentiation degree.

Annarita Pecchi1, Giulia Besutti1, Mario De Santis1, Cinzia Del Giovane1, Sofia Nosseir1, Giuseppe Tarantino1, Fabrizio Di Benedetto1, Pietro Torricelli1.   

Abstract

AIM: To evaluate the relationship between hepatocellular carcinoma (HCC) vascularity and grade; to describe patterns and vascular/histopathological variations of post-transplantation recurrence.
METHODS: This retrospective study included 165 patients (143 men, 22 women; median age 56.8 years, range 28-70.4 years) transplanted for HCC who had a follow-up period longer than 2 mo. Pre-transplantation dynamic computed tomography or magnetic resonance examinations were retrospectively reviewed, classifying HCC imaging enhancement pattern into hypervascular and hypovascular based on presence of wash-in during arterial phase. All pathologic reports of the explanted livers were reviewed, collecting data about HCC differentiation degree. The association between imaging vascular pattern and pathological grade was estimated using the Fisher exact test. All follow-up clinical and imaging data were reviewed for evidence of recurrence. Recurrence rate was calculated and imaging features of recurrent tumor were collected, classifying early and late recurrences based on timing (< or ≥ 2 years after transplantation) and intrahepatic, extrahepatic and both intrahepatic and extrahepatic recurrences based on location. All intrahepatic recurrences were classified as hypervascular or hypovascular and the differentiation degree was collected where available. The presence of variations in imaging enhancement pattern and pathological grade between the primary tumor and the intrahepatic recurrence was evaluated and the association between imaging and histopatholgical variations was estimated by using the χ(2) test.
RESULTS: Of the 163 patients with imaging evidence of viable tumor, 156 (95.7%) had hypervascular and 7 (4.3%) hypovascular HCC. Among the 125 patients with evidence of viable tumor in the explanted liver, 19 (15.2%) had grade 1, 56 (44.8%) grade 2, 40 (32%) grade 3 and 4 (3.2%) grade 4 HCC, while the differentiation degree was not assessable for 6 patients (4.8%). A significant association was found between imaging vascularity and pathological grade (P = 0.035). Post-transplantation recurrence rate was 14.55% (24/165). All recurrences occurred in patients who had a hypervascular primary tumor. Three patients (12.5%) experienced late recurrence; the location of the first recurrence was extrahepatic in 14 patients (58.3%), intrahepatic in 7 patients (29.2%) and both intrahepatic and extrahepatic in 3 patients (12.5%). Two patients had a variation in imaging characteristics between the primary HCC (hypervascular) and the intrahepatic recurrent HCC (hypovascular), while 1 patient had a variation of histopathological characteristics (from moderate to poor differentiation), however no association was found between imaging and histopathological variations.
CONCLUSION: A correlation was found between HCC grade and vascularity; some degree of variability may exist between the primary and the recurrence imaging/histopathological characteristics, apparently not correlated.

Entities:  

Keywords:  Cell differentiation; Contrast media; Hepatocellular carcinoma; Liver transplantation; Recurrence

Year:  2015        PMID: 25729483      PMCID: PMC4342610          DOI: 10.4254/wjh.v7.i2.276

Source DB:  PubMed          Journal:  World J Hepatol


  22 in total

1.  Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: validity of portal phase imaging for predicting tumor grade.

Authors:  Daisuke Okamoto; Kengo Yoshimitsu; Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Kakihara; Tomohiro Nakayama; Yunosuke Nishihara; Shinichi Aishima; Akinobu Taketomi; Junji Kishimoto; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2011-03-21       Impact factor: 3.528

2.  Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.

Authors:  Yoshiki Asayama; Kengo Yoshimitsu; Yunosuke Nishihara; Hiroyuki Irie; Shinichi Aishima; Akinobu Taketomi; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

Review 3.  Recent advances in the natural history of hepatocellular carcinoma.

Authors:  F Trevisani; M C Cantarini; J R Wands; M Bernardi
Journal:  Carcinogenesis       Date:  2008-05-29       Impact factor: 4.944

Review 4.  Imaging of HCC.

Authors:  Carmen Ayuso; Jordi Rimola; Angeles García-Criado
Journal:  Abdom Imaging       Date:  2012-04

5.  Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.

Authors:  Goh Eun Chung; Jeong-Hoon Lee; Jung-Hwan Yoon; Sun Jung Myung; Kyoungbun Lee; Ja June Jang; Jeong Min Lee; Se-Hyung Kim; Kyung-Suk Suh; Yoon Jun Kim; Hyo-Suk Lee
Journal:  Abdom Imaging       Date:  2012-06

Review 6.  Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.

Authors:  Alampady K Shanbhogue; Srinivasa R Prasad; Naoki Takahashi; Raghunandan Vikram; Dushyant V Sahani
Journal:  Radiology       Date:  2011-03       Impact factor: 11.105

7.  Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma.

Authors:  Nefise Cağla Tarhan; Tuğçe Hatipoğlu; Eylül Ercan; Merve Bener; Göksun Keleş; Ceyla Başaran; Banu Bilezikçi
Journal:  Diagn Interv Radiol       Date:  2011-02-15       Impact factor: 2.630

8.  Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.

Authors:  Soon Ho Yoon; Jeong Min Lee; Young Ho So; Sung Hyun Hong; Soo Jin Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

9.  Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features.

Authors:  Young-sun Kim; Hyo K Lim; Hyunchul Rhim; Won Jae Lee; Jae Won Joh; Cheol Keun Park
Journal:  AJR Am J Roentgenol       Date:  2007-08       Impact factor: 3.959

10.  Late recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  Kenneth S H Chok; See Ching Chan; Tan To Cheung; Albert C Y Chan; Sheung Tat Fan; Chung Mau Lo
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

View more
  10 in total

Review 1.  Keys to long-term care of the liver transplant recipient.

Authors:  Kymberly D Watt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-13       Impact factor: 46.802

2.  Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  A Bauschke; A Altendorf-Hofmann; H Kissler; A Koch; C Malessa; U Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

3.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.

Authors:  Xin-Fei Xu; Hao Xing; Jun Han; Zhen-Li Li; Wan-Yee Lau; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Yong-Yi Zeng; Chao Li; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

Review 4.  Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.

Authors:  Jian-Jun Gao; Zhen-Yan Shi; Ju-Feng Xia; Yoshinori Inagaki; Wei Tang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 5.  Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Yves Dittmar; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.

Authors:  Mimi Kim; Tae Wook Kang; Woo Kyoung Jeong; Young Kon Kim; Seong Hyun Kim; Jong Man Kim; Dong Hyun Sinn; Min-Ji Kim; Sin-Ho Jung
Journal:  Eur Radiol       Date:  2016-12-12       Impact factor: 5.315

7.  Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Ming-Da Wang; Chao Li; Lei Liang; Hao Xing; Li-Yang Sun; Bing Quan; Han Wu; Xin-Fei Xu; Meng-Chao Wu; Timothy M Pawlik; Wan Yee Lau; Feng Shen; Tian Yang
Journal:  Oncologist       Date:  2020-06-09       Impact factor: 5.837

8.  CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling.

Authors:  Zibo Chen; Tao Yuan; Fangjie Yan; Song Ye; Qin Xie; Bo Zhang; Nengmin Lin; Qiaojun He; Bo Yang; Hong Zhu
Journal:  BMC Cancer       Date:  2022-04-19       Impact factor: 4.638

9.  Activated platelets inhibit hepatocellular carcinoma cell differentiation and promote tumor progression via platelet-tumor cell binding.

Authors:  Rongfeng Zhang; Huishu Guo; Jingchao Xu; Bing Li; Yue-Jian Liu; Cheng Cheng; Chunyan Zhou; Yongfu Zhao; Yang Liu
Journal:  Oncotarget       Date:  2016-09-13

10.  Reduction of FoxP3+ Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma.

Authors:  Lin Zhou; Li-Chao Pan; Yong-Gen Zheng; Xin-Xue Zhang; Zhi-Jia Liu; Xuan Meng; Hai-Da Shi; Guo-Sheng Du; Qiang He
Journal:  Ann Transl Med       Date:  2020-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.